OBJECTIVES: Studies demonstrate safety and survival benefits of surgical resection in older individuals with pancreatic adenocarcinoma. We investigated treatment disparities by age. METHODS: The Surveillance, Epidemiology, and End Results database for survival and treatment of pancreatic adenocarcinoma between 1983 and 2007 stratified by age: younger than 50 years, between 50 and 70 years, or older than 70 years. Kaplan-Meier curves and Cox proportional hazards models were used for survival differences, and logistic regression models were used for treatment disparities and the decision to refuse surgery. RESULTS: A total of 45,509 patients had microscopically confirmed pancreatic adenocarcinoma. Of these, 7374 (16%) received surgery and 9842 (22%) received radiation. Younger patients were more likely to receive both surgery and radiation. The prevalence of surgery decreased from 21% for those younger than 50 years to 19% for those between 50 and 70 years to 13% for those older than 70 years (P < 0.001). Radiation decreased from 28% to 25% to 17% (P < 0.001). Overall survival decreased with increasing age at diagnosis, 10.4 months (age <50 years) to 9.1 months (age 50-70 years) to 6.4 months (age >70 years) controlling for stage, sex, race, radiation, and surgery (P < 0.001). Increasing age negatively predicted the odds of receiving both surgery and radiation and increased the likelihood of refusing surgery. CONCLUSIONS: Treatment disparities exist by age despite advances in radiation and surgical treatment. Increased treatment in the elderly will increase overall survival from pancreatic adenocarcinoma.
OBJECTIVES: Studies demonstrate safety and survival benefits of surgical resection in older individuals with pancreatic adenocarcinoma. We investigated treatment disparities by age. METHODS: The Surveillance, Epidemiology, and End Results database for survival and treatment of pancreatic adenocarcinoma between 1983 and 2007 stratified by age: younger than 50 years, between 50 and 70 years, or older than 70 years. Kaplan-Meier curves and Cox proportional hazards models were used for survival differences, and logistic regression models were used for treatment disparities and the decision to refuse surgery. RESULTS: A total of 45,509 patients had microscopically confirmed pancreatic adenocarcinoma. Of these, 7374 (16%) received surgery and 9842 (22%) received radiation. Younger patients were more likely to receive both surgery and radiation. The prevalence of surgery decreased from 21% for those younger than 50 years to 19% for those between 50 and 70 years to 13% for those older than 70 years (P < 0.001). Radiation decreased from 28% to 25% to 17% (P < 0.001). Overall survival decreased with increasing age at diagnosis, 10.4 months (age <50 years) to 9.1 months (age 50-70 years) to 6.4 months (age >70 years) controlling for stage, sex, race, radiation, and surgery (P < 0.001). Increasing age negatively predicted the odds of receiving both surgery and radiation and increased the likelihood of refusing surgery. CONCLUSIONS: Treatment disparities exist by age despite advances in radiation and surgical treatment. Increased treatment in the elderly will increase overall survival from pancreatic adenocarcinoma.
Authors: Purvi Parikh; Mira Shiloach; Mark E Cohen; Karl Y Bilimoria; Clifford Y Ko; Bruce L Hall; Henry A Pitt Journal: HPB (Oxford) Date: 2010-09 Impact factor: 3.647
Authors: Samuel Cykert; Peggye Dilworth-Anderson; Michael H Monroe; Paul Walker; Franklin R McGuire; Giselle Corbie-Smith; Lloyd J Edwards; Audrina Jones Bunton Journal: JAMA Date: 2010-06-16 Impact factor: 56.272
Authors: Mara A Schonberg; Edward R Marcantonio; Donglin Li; Rebecca A Silliman; Long Ngo; Ellen P McCarthy Journal: J Clin Oncol Date: 2010-03-22 Impact factor: 44.544
Authors: David T Miyamoto; Harvey J Mamon; David P Ryan; Christopher G Willett; Marek Ancukiewicz; Wendy K Kobayashi; Lawrence Blaszkowsky; Carlos Fernandez-del Castillo; Theodore S Hong Journal: Int J Radiat Oncol Biol Phys Date: 2009-09-30 Impact factor: 7.038
Authors: Ali Abbaszadeh Kasbi; Mohammed Ali Ashary; Mizba Baksh; Samuel Nussbaum; Kristopher Attwood; Emmanuel Gabriel Journal: Cancer Diagn Progn Date: 2022-01-03
Authors: Citadel J Cabasag; Melina Arnold; Mark Rutherford; Aude Bardot; Jacques Ferlay; Eileen Morgan; Alana Little; Prithwish De; Elijah Dixon; Ryan R Woods; Nathalie Saint-Jacques; Sue Evans; Gerda Engholm; Mark Elwood; Neil Merrett; David Ransom; Dianne L O'Connell; Freddie Bray; Isabelle Soerjomataram Journal: Br J Cancer Date: 2022-03-02 Impact factor: 9.075
Authors: Annabelle L Fonseca; Hamza Khan; Krista R Mehari; Deepa Cherla; Martin J Heslin; Fabian M Johnston Journal: Ann Surg Oncol Date: 2022-01-23 Impact factor: 5.344
Authors: Kian-Huat Lim; Emma Langley; Feng Gao; Jingqin Luo; Lin Li; Gary Meyer; Phillip Kim; Sharat Singh; Vladamir M Kushnir; Dayna S Early; Daniel K Mullady; Steven A Edmundowicz; Sachin Wani; Faris M Murad; Dengfeng Cao; Riad R Azar; Andrea Wang-Gillam Journal: Oncotarget Date: 2017-04-11
Authors: Olusola O Faluyi; Joanna L Connor; Madhuchanda Chatterjee; Carl Ikin; Helen Wong; Daniel H Palmer Journal: Br J Cancer Date: 2017-01-12 Impact factor: 7.640